Daffy

Institute of Quantitative Systems Pharmacology Iqsp

Institute of Quantitative Systems Pharmacology Iqsp

Carlsbad, CA
Tax ID81-2862096

Want to make a donation using Daffy?

Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.

Payment method

Frequency

Amount

$USD
Daffy covers all ACH transaction fees so 100% of your donation goes to your favorite charities.

Do you work for Institute of Quantitative Systems Pharmacology Iqsp? Learn more here.

By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.

About this organization

Revenue

$2,163,582

Expenses

$87,360

Website

i-qsp.org

Mission

IQSP's mission is to advance drug development through instruction in and application of quantitative systems pharmacology

About

QSP-based research in drug development. Two postdoctoral researchers and a senior scientist worked on long-standing enigmas in drug delivery and intracellular transport with significant relevance to drug development. The research results were disseminated at the annual Experimental Biology meeting in abstracts entitled: Quantitative pharmacology of internalization, intracellular trafficking and gene silencing of siRNA; Quantitative pharmacology to interrogate mechanisms of lipoplex destabilization by serum proteins; Quantitative pharmacology of intercellular drug shuttle by exosomes; Polyanionic drugs reduce intracellular bioavailability and transfection efficiency of cationic siRNA lipoplex: quantitative pharmacology studies Quantitative systems pharmacology on combination gene-targeting therapyInhibition of exosome-mediated efflux produces synergy with paclitaxel

Interesting data from their 2019 990 filing

The purpose of the non-profit is outlined in the filing as “Iqsp's mission is to advance drug development through instruction in and application of quantitative systems pharmacology”.

When discussing its operations, they were defined as: “Iqsp's mission is to advance drug development through instruction in and application of quantitative systems pharmacology”.

  • The state where the non-profit operates has been legally reported as CA.
  • The non-profit has reported 2 employees on their form as of 2019.
  • Does not operate a hospital.
  • Does not operate a school.
  • Does not collect art.
  • Does not provide credit counseling.
  • Does not have foreign activities.
  • Is not a donor-advised fund.
  • Is not a private foundation.
  • Expenses are less than $100,000.
  • Revenue is greater than $1,000,000.
  • Revenue less expenses is $2,076,222.
  • The CEO's remuneration policy within the organization is established through an impartial review and endorsement process.
  • The organization has a written policy that describes how long it will retain documents.
  • The organization has 2 independent voting members.
  • The organization was formed in 2016.
  • The organization has a written policy that addresses conflicts of interest.
  • The organization is required to file Schedule B.
  • The organization pays $74,589 in salary, compensation, and benefits to its employees.
  • The organization pays $0 in fundraising expenses.
  • The organization has minutes of its meetings.
  • The organization has a written whistleblower policy.